LMR Partners’s Drugs Made In America Acquisition Corp DMAA Stock Holding History

LMR Partners’s Portfolio DMAA Stock Details DMAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-500,000	Closed	-$5.24M	–	1868
2026 Q1	$5.24M	Hold	500,000	–	–	0.01%	612
2025 Q4	$5.19M	Hold	500,000	–	–	0.01%	561
2025 Q3	$5.14M	Hold	500,000	–	–	0.02%	513
2025 Q2	$5.1M	Hold	500,000	–	–	0.04%	440
2025 Q1	$5.01M	Buy	+500,000	New	+$5M	0.05%	407

Other funds holding DMAA

Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

LMR Partners's DMAA Position: Q2 2026 in Review

LMR Partners sold out of Drugs Made In America Acquisition Corp (DMAA) in Q2 2026, closing a stake of 500,000 shares — an estimated $5.24M sold.

LMR Partners first reported a position in DMAA in Q1 2025 and held it in 5 quarters. The position peaked at $5.24M in Q1 2026. 23 funds tracked by Wall St. Rank hold DMAA as of Q2 2026.

LMR Partners reported no remaining Drugs Made In America Acquisition Corp position as of Q2 2026 after selling out during the quarter.
LMR Partners sold 500,000 Drugs Made In America Acquisition Corp shares in Q2 2026, an estimated $5.24M.
LMR Partners first reported a position in Drugs Made In America Acquisition Corp in Q1 2025 and held it in 5 quarters.
LMR Partners's Drugs Made In America Acquisition Corp position peaked at $5.24M in Q1 2026.
23 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.